Automated Insulin Delivery Associated with Superior Glycemic Outcomes in Type 1 Diabetes: A Swedish National Registry Analysis
In a nationwide RWD analysis, AID use was consistently associated with clinically and statistically significant HbA1c reductions in adults with T1D, with the greatest effect for Tandem Control-IQ technology. These findings align with RCTs and international RWD, supporting AID as a preferred technology in routine diabetes care for T1D.
Authors
- Fredrik Ståhl (ORCID: https://orcid.org/0000-0002-9690-0286)
- Jarl Hellman (ORCID: https://orcid.org/0000-0001-6187-5511)
- C. K. Ekelund (ORCID: https://orcid.org/0000-0002-8337-5101)
Institutions
- Uppsala University (SE)
- Uppsala University Hospital (SE)
- Malmö University (SE)
- Nordvästra Skånes Vatten och Avlopp (Sweden) (SE)
- Cytodiagnostics (Canada) (CA)
- Department of Medical Sciences (RU)
Publication Details
- Journal
- Diabetes Technology & Therapeutics
- Published
- 2026-01-23
- DOI
- https://doi.org/10.1177/15209156251414976
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00